What Makes the Gut-Lung Axis Working? From the Perspective of Microbiota and Traditional Chinese Medicine

Hui Wang,Ying Wang
DOI: https://doi.org/10.1155/2024/8640014
2024-01-19
Canadian Journal of Infectious Diseases and Medical Microbiology
Abstract:Background. An increasing number of studies have proved that gut microbiota is involved in the occurrence and development of various lung diseases and can interact with the diseased lung. The concept of the gut-lung axis (GLA) provides a new idea for the subsequent clinical treatment of lung diseases through human microbiota. This review aims to summarize the microbiota in the lung and gut and the interaction between them from the perspectives of traditional Chinese medicine and modern medicine. Method. We conducted a literature search by using the search terms "GLA," "gut microbiota," "spleen," and "Chinese medicine" in the databases PubMed, Web of Science, and CNKI. We then explored the mechanism of action of the gut-lung axis from traditional Chinese medicine and modern medicine. Results. The lung and gut microbiota enable the GLA to function through immune regulation, while metabolites of the gut microbiota also play an important role. The spleen can improve the gut microbiota to achieve the regulation of the GLA. Conclusion. Improving the gut microbiota through qi supplementation and spleen fortification provides a new approach to the clinical treatment of lung diseases by regulating the GLA. Currently, our understanding of the GLA is limited, and more research is needed to explain its working principle.
infectious diseases,microbiology
What problem does this paper attempt to address?
The paper attempts to address the relationship between gut microbiota and lung diseases, as well as the potential of treating lung diseases by modulating gut microbiota. Specifically, the article reviews the interactions between gut and lung microbiota and their impact on the gut-lung axis (GLA) function from the perspectives of modern medicine and traditional Chinese medicine (TCM). The paper emphasizes the important role of the spleen in improving gut microbiota and subsequently regulating the GLA, and proposes a new clinical approach to treating lung diseases through methods of tonifying Qi and strengthening the spleen. The main content of the article includes: 1. **Background**: Increasing research has shown that gut microbiota is involved in the onset and development of various lung diseases. The concept of the gut-lung axis provides new ideas for subsequent clinical treatment of lung diseases through the human microbiota. 2. **Methods**: Literature searches were conducted in PubMed, Web of Science, and CNKI databases using keywords such as "GLA," "gut microbiota," "spleen," and "traditional Chinese medicine." The mechanisms of the gut-lung axis were explored. 3. **Results**: Lung and gut microbiota exert their effects on the GLA through immune regulation, and metabolites of gut microbiota also play an important role. The spleen can improve gut microbiota, thereby achieving regulation of the GLA. 4. **Conclusion**: Improving gut microbiota through tonifying Qi and strengthening the spleen provides a new approach for the clinical treatment of lung diseases by regulating the GLA. Currently, the understanding of the GLA is still limited, and more research is needed to elucidate its working mechanisms. Additionally, the article discusses in detail the specific roles of gut and lung microbiota and their importance in maintaining human health, as well as the key role of the spleen-lung relationship in TCM theory in establishing the GLA.